Yan Peng MD PhD

Professor #Pathology #Breastpath #GYNpath @UTSWNews, Alumnus #Mayo @BIDMC @UPMC, Coeditor of Practical Breast Pathology, Editorial board member @Human_Pathology

[UTSW Simmons Cancer Center @utswcancer]

We’re honored to announce that @UTSWMedCenter has been recognized by @Newsweek as one of the 2027 World’s Best Specialized Hospitals for Oncology. This recognition reflects the expertise, innovation, and dedication of our teams providing exceptional cancer care.

[Cancers MDPI @Cancers_MDPI]

🌟New #SpecialIssue: The Molecular #Pathology of #BreastCancer: Insights into Tumor #Biology, Prognostic #Biomarkers, and Potential Therapeutic #Targets
👥Guest Editors: @YanPengB553S & Dr. Gregor J. Krings
🔔Submission Deadline: 31 March 2027
Link🔗https://t.co/I0aknzr6Gx

[Human Pathology @Human_Pathology]

New in #HumPathol: TRPS1 and GATA3 Expression in BRG1/SMARCA4-deficient Malignant Neoplasms. https://t.co/RmOrcvTSYW #pathology #PathTwitter #PathX #breastpath

[Paolo Tarantino @PTarantinoMD]

Some studies suggested better outcomes for HER2-low (vs 0) mTNBC. We centrally reviewed samples from 196 patients with mTNBC, finding a significant association between AR and HER2-low exp which may explain the prognostic differences. Read the article here: https://t.co/MAyh4CZ5r6

[Dana-Farber News @DanaFarberNews]

Cancer care and AI: Dr. Eli Van Allen will deliver the #ASCOGU26 keynote address on “Reimagining Cancer Research and Care in the AI Age.” @VanAllenLab

Read more in The @ASCOPost ➡️ https://t.co/nCQpo9m9wa

[Xia & He Publishing @xiahepublishing]

Congratulations! Journal of Clinical and Translational Pathology has been accepted by ESCI (Emerging Sources Citation Index).
Thank you all for your support and assistance!👥 @gcai1978 @CAPA_comm

https://t.co/kK8ImDSjig
#JCTP #ESCI #Pathology #TranslationalResearch #Indexed

[Cancers MDPI @Cancers_MDPI]

📢Check out the Highly Viewed Papers and Hot Topic Special Issues in the “Cancer #Pathophysiology” Section
🤗 Find more details here:
https://t.co/C0WOMwzjUK

#CancersMDPI #OpenAccess 🔓 #HighlyView #SpecialIssue #HotTopic #CallforPapers

[Cancers MDPI @Cancers_MDPI]

💡This #review highlights the evolving role of multiomics in deepening our understanding of #TNBC biology, especially tumor heterogeneity, ultimately contributing to the development of novel therapies.
✍️By Conan Juan & @YanPengB553S
Read in @Cancers_MDPI👉https://t.co/n9rr76AmNI

[Chinese American Pathologists Association @CAPA_comm]

CAPA education program & official journal-JCTP

[Yan Peng MD PhD @YanPengB553S]

@Human_Pathology Honored to collaborate with talented pathologists from leading institutions on this special issue, featuring recent advances closely tied to breast cancer care. Grateful for their contributions and inspiring collaboration!
@UTSWMedCenter @utswcancer @UTSW_Pathology

[Human Pathology @Human_Pathology]

The August 2025 issue of #HumPathol is available online! This is a special issue on breast pathology, edited by @YanPengB553S. https://t.co/WzVaoPkhTQ #pathology #PathTwitter #PathX #breastpath

[Xia & He Publishing @xiahepublishing]

🎉🎉 Good news: JCTP successfully passed the rigorous evaluation by the Committee on Publication Ethics (COPE) and was officially accepted as a COPE member journal.@UMiamiPathology@UNMC_PathMicro

👥 @gcai1978 @CAPA_comm

[Guoping Cai, MD @gcai1978]

The 2nd issue of JCTP has just published online. Thank all authors, reviewers and editorial staff who make this possible. Here is the link for the full content: https://t.co/ksOuZO7gbC

[Human Pathology @Human_Pathology]

New in #HumPathol: Updates and Controversies in Breast Pathology. https://t.co/a3nLdS0iPO #pathology #PathTwitter #PathX #breastpath

[Human Pathology @Human_Pathology]

New in #HumPathol: Genetic Landscapes of Breast Tumors by Next-Generation Sequencing with Focus on Less Common Types and Genotype-Phenotype Correlations. https://t.co/E20iThXZHy #pathology #PathTwitter #PathX #breastpath

[Human Pathology @Human_Pathology]

New in #HumPathol: Updates on Utility of Immunohistochemistry in Diagnosis of Metastatic Breast Cancer. https://t.co/Q1fouk0OIc #pathology #PathTwitter #PathX #breastpath #IHCpath

[Human Pathology @Human_Pathology]

New in #HumPathol: Artificial intelligence in breast pathology: overview and recent updates. https://t.co/Z5X549mrvx #pathology #PathTwitter #PathX #breastpath #AIpath

[Human Pathology @Human_Pathology]

New in #HumPathol: CIC-rearranged sarcoma in the breast: A series of 3 rare cases with literature review. https://t.co/SBkOOoxxig #pathology #PathTwitter #PathX #breastpath #BSTpath

[Guoping Cai, MD @gcai1978]

The 2025 first issue of JCTP has just been published online. We would like to thank all authors and reviewers for their contributions and support. @CAPA_comm Please use the following link for full access to the issue. https://t.co/1dljvg8Pdj

[Hannah Wen @HannahYWen]

FDA Approves Trastuzumab Deruxtecan for Pretreated HER2-Low and -Ultralow Metastatic Breast Cancer https://t.co/aI51H6Jxk6 via @onclive